Patents by Inventor Duen-Ren Hou

Duen-Ren Hou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted 1,2,3-triazoles as antitumor agents
    Patent number: 9738613
    Abstract: Compounds represented by Formula I: and/or a pharmaceutically acceptable salts, a prodrug, a solvate and a combination thereof, a pharmaceutical composition including the triazole derivative, and a method of treating a cancer disease in an individual are disclosed.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: August 22, 2017
    Assignee: National Central University
    Inventors: Duen-Ren Hou, Sharada Prasanna Swain
  • Method for synthesizing of thioesters by using compound as catalyst
    Patent number: 9567297
    Abstract: A method for synthesizing of thioesters by using a compound as a catalyst is disclosed. The compound is represented by formula I below: In formula I, R5 represents H, a substituted or unsubstituted alkyl, a substituted or unsubstituted aryl, or a substituted or unsubstituted heteroaryl; X and Y each independently represents one of H, C1-10 alkyl, C5-10 aryl, C1-10 alkyl alcohol, thiohydroxy, carbonyl, sulfonyl, sulfamoyl, carbamoyl, C1-10 alkoxycarbonyl, C1-10 alkoxycarbamoyl, C1-10 alkylamino, C1-10 alkylsulfonyl, C1-10 haloalkylsulfonyl, ureido, amido, and C1-10 alkoxylcarbamoyl; and n is 0, 1, 2, 3, 4 or 5.
    Type: Grant
    Filed: October 16, 2015
    Date of Patent: February 14, 2017
    Assignee: National Central University
    Inventors: Duen-Ren Hou, Sharada Prasanna Swain
  • Substituted 1,2,3-Triazoles as Antitumor Agents
    Publication number: 20160340321
    Abstract: Compounds represented by Formula I: and/or a pharmaceutically acceptable salts, a prodrug, a solvate and a combination thereof, a pharmaceutical composition including the triazole derivative, and a method of treating a cancer disease in an individual are disclosed.
    Type: Application
    Filed: May 18, 2015
    Publication date: November 24, 2016
    Inventors: Duen-Ren Hou, Sharada Prasanna Swain
  • Method for Synthesizing of Thioesters by Using Compound as Catalyst
    Publication number: 20160340303
    Abstract: A method for synthesizing of thioesters by using a compound as a catalyst is disclosed. The compound is represented by formula I below: In formula I, R5 represents H, a substituted or unsubstituted alkyl, a substituted or unsubstituted aryl, or a substituted or unsubstituted heteroaryl; X and Y each independently represents one of H, C1-10 alkyl, C5-10 aryl, C1-10 alkyl alcohol, thiohydroxy, carbonyl, sulfonyl, sulfamoyl, carbamoyl, C1-10 alkoxycarbonyl, C1-10 alkoxycarbamoyl, C1-10 alkylamino, C1-10 alkylsulfonyl, C1-10 haloalkylsulfonyl, ureido, amido, and C1-10 alkoxylcarbamoyl; and n is 0, 1, 2, 3, 4 or 5.
    Type: Application
    Filed: October 16, 2015
    Publication date: November 24, 2016
    Inventors: Duen-Ren Hou, Sharada Prasanna Swain
  • 1, 2, 3-triazole derivatives as new cannabinoid-1 receptor antagonists
    Patent number: 8293773
    Abstract: The present invention relates to 1,2,3-triazole derivatives which can be used as cannabinoid CB1 receptor antagonists. In addition, the compound of the 1,2,3-triazole derivatives in the present invention can be formulated into a pharmaceutical composition for treating indications relative to signal transduction of CB1 receptors.
    Type: Grant
    Filed: November 13, 2009
    Date of Patent: October 23, 2012
    Assignee: National Tsing Hua University
    Inventors: Duen-Ren Hou, Ming-Shiu Hung, Chun-Chen Liao, Chun-Cheng Lin
  • 1, 2, 3-Triazole derivatives as new cannabinoid-1 receptor antagonists
    Publication number: 20100144734
    Abstract: The present invention relates to 1,2,3-triazole derivatives which can be used as cannabinoid CB1 receptor antagonists. In addition, the compound of the 1,2,3-triazole derivatives in the present invention can be formulated into a pharmaceutical composition for treating indications relative to signal transduction of CB1 receptors.
    Type: Application
    Filed: November 13, 2009
    Publication date: June 10, 2010
    Applicant: National Tsing Hua University
    Inventors: Duen-Ren Hou, Ming-Shiu Hung, Chun-Chen Liao, Chun-Cheng Lin